Trinity Biotech (TRIB) Beginning Cash Balance (2009 - 2024)

Trinity Biotech (TRIB) has reported Beginning Cash Balance for 16 consecutive years, with $2.8 million the latest figure, recorded in Q4 2024.

• Quarterly Beginning Cash Balance fell 54.64% year-over-year to $2.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $42.3 million (down 36.82% YoY) and the FY2024 annual result came in at $3.7 million, down 43.89% from the prior year.
• Beginning Cash Balance slipped to $2.8 million in Q4 2024 per TRIB's latest filing, from $6.3 million in the prior quarter.
• Over the last five years, Beginning Cash Balance for TRIB reached as high as $32.3 million in Q2 2021 and fell as low as $2.8 million in Q4 2024.
• A 5-year average of $18.6 million and a median of $18.2 million in 2020 frame the typical range for Beginning Cash Balance.
• Annual changes were most pronounced in 2021 — Beginning Cash Balance jumped 143.71% — and 2022, when it tumbled 73.6%.
• Year by year, Beginning Cash Balance stood at $19.9 million in 2020, then surged by 38.0% to $27.5 million in 2021, then slumped by 73.6% to $7.3 million in 2022, then slipped by 13.69% to $6.3 million in 2023, then sank by 54.64% to $2.8 million in 2024.
• According to Business Quant data, Beginning Cash Balance over the past three periods registered $2.8 million, $6.3 million, and $7.3 million for Q4 2024, Q4 2023, and Q4 2022 respectively.